LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: COVID-19 Induced Hemophagocytic Lymphohistiocytosis in a Patient with Novel Homozygous UNC13D Gene Variant.

    Tekeli, Seher / Erman, Baran / Kurucu, Burcak / Tanir, Gonul / Aytekin, Caner

    Klinische Padiatrie

    2023  Volume 235, Issue 4, Page(s) 258–260

    Title translation COVID-19-induzierte hämophagozytische Lymphohistiozytose bei einem Patienten mit neuartiger homozygoter UNC13D-Genvariante.
    MeSH term(s) Humans ; COVID-19 ; Homozygote ; Lymphohistiocytosis, Hemophagocytic/diagnosis ; Lymphohistiocytosis, Hemophagocytic/genetics ; Membrane Proteins/genetics ; Mutation
    Chemical Substances Membrane Proteins ; UNC13D protein, human
    Language English
    Publishing date 2023-07-07
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 120650-3
    ISSN 1439-3824 ; 0300-8630
    ISSN (online) 1439-3824
    ISSN 0300-8630
    DOI 10.1055/a-2081-0522
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Treatment of tuberous sclerosis complex manifestations in children with mTOR inhibitors.

    Yeşil, Şule / Kurucu, Burçak / Hamamcı, Melda Berber / Yılmaz, Şükriye / Şahin, Gürses

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

    2023  Volume 40, Issue 3, Page(s) 831–837

    Abstract: Purpose: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder that affects multiple organ systems. Mutations in the TSC1 and TSC2 genes result in the constitutive hyperactivation of the mammalian target of rapamycin (mTOR) ... ...

    Abstract Purpose: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder that affects multiple organ systems. Mutations in the TSC1 and TSC2 genes result in the constitutive hyperactivation of the mammalian target of rapamycin (mTOR) pathway, contributing to the growth of benign tumors or hamartomas in various organs. Due to the implication of mTOR pathway dysregulation in the disease pathology, increasing evidence supports the use of mTOR inhibitors for treating multiple manifestations of TSC.
    Methods: In this study, we conducted a retrospective analysis of clinical findings and treatment data from 38 patients diagnosed with tuberous sclerosis who were followed up in the Pediatric Oncology Clinic between 2010 and 2020. We collected information on patients' ages, genders, affected sites, familial history, imaging findings, presence of tumors, and treatments.
    Results: Among the patients, nine individuals with TSC manifestations were treated with mTOR inhibitors. Specifically, everolimus was successfully administered to five patients with inborn cardiac rhabdomyoma causing hemodynamic impairment. In addition, two patients with refractory seizures received everolimus in combination with anti-epileptic drugs. A patient with renal angiomyolipomas larger than 3 cm was treated with everolimus, while a patient with extensive facial angiofibroma received topical sirolimus. All patients tolerated the mTOR inhibitors well, and the side effects were deemed acceptable.
    Conclusion: The utilization of mTOR inhibition in TSC is expected to become more prevalent in clinical practice, as current research is anticipated to provide a better understanding of the therapeutic roles of these treatments in TSC.
    MeSH term(s) Child ; Humans ; Female ; Male ; Everolimus/therapeutic use ; Tuberous Sclerosis/complications ; Tuberous Sclerosis/drug therapy ; Tuberous Sclerosis/genetics ; MTOR Inhibitors ; Retrospective Studies ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism ; TOR Serine-Threonine Kinases/therapeutic use ; Sirolimus/therapeutic use
    Chemical Substances Everolimus (9HW64Q8G6G) ; MTOR Inhibitors ; TOR Serine-Threonine Kinases (EC 2.7.11.1) ; Sirolimus (W36ZG6FT64)
    Language English
    Publishing date 2023-11-10
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 605988-0
    ISSN 1433-0350 ; 0302-2803 ; 0256-7040
    ISSN (online) 1433-0350
    ISSN 0302-2803 ; 0256-7040
    DOI 10.1007/s00381-023-06218-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: [No title information]

    Tekeli, Seher / Erman, Baran / Kurucu, Burcak / Tanir, Gonul / Aytekin, Caner

    Klinische Pädiatrie

    2023  Volume 235, Issue 04, Page(s) 258–260

    Language English
    Publishing date 2023-07-01
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 120650-3
    ISSN 1439-3824 ; 0300-8630
    ISSN (online) 1439-3824
    ISSN 0300-8630
    DOI 10.1055/a-2081-0522
    Database Thieme publisher's database

    More links

    Kategorien

  4. Article ; Online: Evaluation of adolescents with heavy menstrual bleeding using the International Society of Thrombosis Haemostasis- Bleeding Assessment Tool and The Pediatric Bleeding Questionnaire scores.

    Öner, Nergiz / Şahin, Gürses / Yeşil, Şule / Kurucu, Burçak / Çapkınoğlu, Emre / Kılcı, Azize Ceren / Gök, Şeyma Ünüvar / Fettah, Ali

    The Turkish journal of pediatrics

    2023  Volume 65, Issue 2, Page(s) 301–308

    Abstract: Background: Heavy menstrual bleeding (HMB) is a common condition in adolescents. However, bleeding disorders are known to be one of the causes of HMB in adolescent girls, so they should be considered. Simple methods that can be used in primary health ... ...

    Abstract Background: Heavy menstrual bleeding (HMB) is a common condition in adolescents. However, bleeding disorders are known to be one of the causes of HMB in adolescent girls, so they should be considered. Simple methods that can be used in primary health care are needed to determine whether patients have bleeding disorders. The aim of this study was to evaluate the bleeding score of patients admitted with HMB and to determine the diagnostic value of patients who were symptomatic but whose initial hemostatic tests were normal.
    Methods: A total of 113 adolescents with HMB and 20 healthy adolescent girls were included in the study. The Pediatric Bleeding Questionnaire (PBQ) and the International Society of Thrombosis Haemostasis-Bleeding Assessment Tool (ISTH-BAT) were used for evaluation.
    Results: Overall, approximately 18% (n= 20) of the adolescents in the study were diagnosed with a bleeding disorder. The cut off value for the `clinically significant bleeding score` was found to be 3.5.
    Conclusions: The PBQ and ISTH-BAT can help distinguish a significant bleeding history from an otherwise trivial bleeding and can be included in the algorithm for the primary care of adolescents with HMB with suspected bleeding disorders.
    MeSH term(s) Female ; Humans ; Child ; Adolescent ; Menorrhagia/diagnosis ; Menorrhagia/etiology ; Hemostasis ; Thrombosis/diagnosis ; Surveys and Questionnaires
    Language English
    Publishing date 2023-04-28
    Publishing country Turkey
    Document type Journal Article
    ZDB-ID 123487-0
    ISSN 2791-6421 ; 0041-4301
    ISSN (online) 2791-6421
    ISSN 0041-4301
    DOI 10.24953/turkjped.2022.761
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Dynamic Thiol-Disulfide Homeostasis in Children With β-Thalassemia Trait.

    Kurucu, Burçak / Fettah, Ali / Çapkınoğlu, Emre / Öner, Nergiz / Eren, Funda / Erel, Özcan / Yeşil, Şule / Şahin, Gürses

    Hemoglobin

    2022  Volume 46, Issue 3, Page(s) 164–167

    Abstract: In children with β-thalassemia (β-thal) trait, tissue damage occurs with oxidative stress due to oxygen free radicals and reactive oxygen species (ROS) production. Dynamic thiol-disulfide homeostasis (DTDH) is one of the most important indicators showing ...

    Abstract In children with β-thalassemia (β-thal) trait, tissue damage occurs with oxidative stress due to oxygen free radicals and reactive oxygen species (ROS) production. Dynamic thiol-disulfide homeostasis (DTDH) is one of the most important indicators showing the pro-oxidant/antioxidant status in the body. In this study, we aimed to examine the status of DTDH by measuring native thiol, disulfide, and total thiol levels in children with β-thal trait. The study included 40 children with β-thal trait and 30 healthy controls (matched by age and gender). The DTDH parameters were measured by an automated method and results were compared between the groups. The levels of native thiol, total thiol, and disulfide in children with β-thal trait group were statistically significantly higher than the control group (
    MeSH term(s) Antioxidants ; Biomarkers ; Child ; Disulfides/metabolism ; Ferritins ; Hemoglobins ; Homeostasis/physiology ; Humans ; Oxidative Stress/physiology ; Reactive Oxygen Species ; Sulfhydryl Compounds ; beta-Thalassemia
    Chemical Substances Antioxidants ; Biomarkers ; Disulfides ; Hemoglobins ; Reactive Oxygen Species ; Sulfhydryl Compounds ; Ferritins (9007-73-2)
    Language English
    Publishing date 2022-05-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 750615-6
    ISSN 1532-432X ; 0363-0269
    ISSN (online) 1532-432X
    ISSN 0363-0269
    DOI 10.1080/03630269.2022.2070073
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Evaluation of the Attitude of Parents in Pediatric Oncology Towards COVID-19 Vaccine.

    Kilci, Ceren / Fettah, Ali / Çapkinoğlu, Emre / Kurucu, Burçak / Ünüvar Gök, Şeyma / Yeşil, Şule / Berber Hamamci, Melda / Şahin, Gürses

    Journal of pediatric hematology/oncology

    2022  Volume 45, Issue 1, Page(s) e14–e16

    Abstract: Severe acute respiratory syndrome, coronavirus (SARS, COVID-19) has been declared a pandemic by the World Health Organization since March 2020. Patients with active cancer should be considered especially for priority access to the COVID-19 vaccine. ... ...

    Abstract Severe acute respiratory syndrome, coronavirus (SARS, COVID-19) has been declared a pandemic by the World Health Organization since March 2020. Patients with active cancer should be considered especially for priority access to the COVID-19 vaccine. Therefore, our study aimed to learn parents' opinions of cancer-diagnosed patients about the COVID-19 vaccine. Between December 2021 and January 2022, 76 people were willing to answer the questionnaire from the parents of outpatient/inpatient patients at the Pediatric Hematology and Oncology Clinic of Dr. Sami Ulus Obstetrics, Child Health and Diseases Education Research Hospital were included. In our study, 18 parents (23.7%) did not get vaccinated. Among the reasons for not getting vaccinated, the most common answer for "I fear from the vaccine's side effects.", "Do you think oncology patients are at risk for COVID-19?", "Do you think the COVID-19 pandemic affects cancer treatment?" were 90.7%, 89.5% and 21% yes, respectively. Would your opinion of the vaccine be positive if the domestic vaccine was produced?"-67.4% answered yes. Vaccine hesitation and public misinformation put cancer patients at risk. Increasing awareness of the rejection of COVID-19 vaccines is important for public health and the fight against the pandemic. In addition, the doctors' recommendations for conducting oncology treatment will significantly impact parents' compliance with the COVID-19 vaccine.
    MeSH term(s) Child ; Female ; Pregnancy ; Humans ; COVID-19 Vaccines/therapeutic use ; COVID-19/prevention & control ; Pandemics ; Medical Oncology ; Drug-Related Side Effects and Adverse Reactions ; Vaccination ; Parents
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2022-08-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1231152-2
    ISSN 1536-3678 ; 1077-4114 ; 0192-8562
    ISSN (online) 1536-3678
    ISSN 1077-4114 ; 0192-8562
    DOI 10.1097/MPH.0000000000002516
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study.

    Çağlayan, Şengül / Koç, Begüm Şirin / Baba, Özge / Bağlan, Esra / Kurucu, Burçak / Yıldırım, Deniz Gezgin / Ayhan, Aylin Canbolat / Çakan, Mustafa / Yener, Gülçin Otar / Öztürk, Kübra / Çakmak, Figen / Sönmez, Hafize Emine / Ayaz, Nuray Aktay / Kısaarslan, Ayşenur Paç / Bakkaloğlu, Sevcan / Kalyoncu, Mukaddes / Kılıç, Suar Çakı / Sözeri, Betül

    The Turkish journal of pediatrics

    2024  Volume 66, Issue 1, Page(s) 81–89

    Abstract: Background: The aim of the study was to evaluate the approaches of pediatric rheumatologists and pediatric hematologists to patients with similar musculoskeletal (MSK) complaints and to highlight the differences that general pediatricians should ... ...

    Abstract Background: The aim of the study was to evaluate the approaches of pediatric rheumatologists and pediatric hematologists to patients with similar musculoskeletal (MSK) complaints and to highlight the differences that general pediatricians should consider when referring patients to these specialties.
    Methods: This is a cross-sectional study involving the patients who applied to pediatric rheumatology centers with MSK complaints and were diagnosed with malignancy, as well as patients who were followed up in pediatric hematology centers with a malignancy diagnosis, and had MSK complaints at the time of admission.
    Results: A total of 142 patients were enrolled in the study. Of these patients, 83 (58.4%) applied to pediatric rheumatology centers, and 59 (41.6%) applied to pediatric hematology centers. Acute lymphoblastic leukemia (ALL) was the most common diagnosis among the patients who applied to both centers, with 80 cases (56.3%). The median age of diagnosis was 87 (interquartile range, IQR: 48-140) months. The most common preliminary diagnosis in pediatric rheumatology centers was juvenile idiopathic arthritis (JIA), with 37 cases (44.5%). MSK involvement was mainly seen as arthralgia, and bone pain. While arthralgia (92.7%) was the most common complaint in rheumatology centers, bone pain (88.1%) was more common in hematology centers. The most frequently involved joints were the knee (62.9%), ankle (25.9%), hip (25%), and wrist (14%). The most common laboratory abnormalities were high lactate dehydrogenase (LDH), high C-reactive protein (CRP), anemia, and high erythrocyte sedimentation rate (ESR). Thrombocytopenia, neutropenia, and high LDH were statistically significantly more frequent in patients admitted to hematology centers than in patients admitted to rheumatology centers (p < 0.001, p=0.014, p=0.028, respectively). Patients who applied to rheumatology clinics were found to have statistically significantly higher CRP levels (p=0.032).
    Conclusions: Malignancies may present with only MSK system complaints in childhood. Therefore, malignancies should be included in the differential diagnosis of patients presenting with MSK complaints.
    MeSH term(s) Child ; Humans ; Child, Preschool ; Cross-Sectional Studies ; Retrospective Studies ; Neoplasms/complications ; Neoplasms/diagnosis ; Arthritis, Juvenile/diagnosis ; Arthralgia
    Language English
    Publishing date 2024-03-25
    Publishing country Turkey
    Document type Multicenter Study ; Journal Article
    ZDB-ID 123487-0
    ISSN 2791-6421 ; 0041-4301
    ISSN (online) 2791-6421
    ISSN 0041-4301
    DOI 10.24953/turkjped.2023.446
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top